See more on startup investing from Benzinga.
But shows the potential upside with diversifying into different investment sectors. This move into healthcare is a bit of contrast to the normal tech plays billionaires tend to flock towards. But investors do have options if they’re looking to invest in healthcare startups. is a private startup, so investors are out of luck. Following in the footsteps of these magnates in these holdings are a pretty easy and straightforward option. This means at least four prominent billionaires are using some of the biggest companies in the world to invest in healthcare.įor Investors: There are a number of options for investors. Cuban’s startup being an example of the potential upside in startup investing and private markets. This has been one of his biggest focal points of the past two years and likely what the billionaire wants to be his legacy. In competition with Amazon, entrepreneur and TV personality Mark Cuban rolled out his Mark Cuban’s Cost Plus Drugs Co. This comes after the full rollout of Amazon Pharmacy, other ventures around telehealth and significant investments in the space. Earlier this year, Amazon rolled out a low-cost subscription service for generic medications to Prime members. Amazon officially closed its $3.9 billion acquisition of One Medical earlier this week. also is quickly becoming a healthcare powerhouse. In a recent interview, Dalio noted that biotech is one of the current investment areas he finds interesting. Collectively, they make up 7.57% of the entire hedge fund’s portfolio. (NYSE: PG) and Johnson & Johnson (NYSE: JNJ). Two of its largest holdings are in Procter & Gamble Co.
Ray Dalio, founder of Bridgewater Associates, the largest hedge fund in the world, is making similar bets. To stay updated with top startup investments, sign up for Benzinga’s Startup Investing & Equity Crowdfunding Newsletter But a number of other notable billionaires also are making similar headway into the healthcare industry. In a vacuum, this may or may not be significant. Horizon is a biotechnology company developing cures for rare and rheumatic diseases. Soros recently purchased $325 million worth of Horizon Therapeutics PLC (NASDAQ: HZNP), which now makes up 5.54% of his portfolio, despite previously owning none of it. The Soros Fund Management Holdings 13F was recently released, and a new company tops the list as its biggest holding. Hedge fund manager George Soros is a polarizing figure, but you’d be foolish not to take notice of some of his investing trends. They might see trends months in advance that others might not notice until it’s too late. The pieces often don’t come together immediately, but these investors have millions of dollars in resources dedicated to getting the most up-to-date information as quickly as possible. When billionaires jump on the same trend, it’s important for investors to take notice.
0 kommentar(er)
